Zobrazeno 1 - 10
of 23
pro vyhledávání: '"E D Savlov"'
Autor:
Sidney H. Sobel, E D Savlov, A Mittleman, D A Amato, W D DeWys, H J Lerner, M J Shiraki, R C Urtasun
Publikováno v:
Journal of Clinical Oncology. 5:613-617
Forty-seven patients with stage I, II, or III soft tissue sarcoma were entered into a prospective randomized Eastern Cooperative Oncology Group (ECOG) adjuvant protocol. Eligibility included conservative or radical primary treatment for local cure. P
Publikováno v:
The American Journal of the Medical Sciences. 258:245-259
Publikováno v:
Cancer. 45(8)
The value of estrogen receptor (ER) analysis in primary breast cancer samples as a potential prognostic factor was examined in three clinical situations: time to recurrence in patients with no therapy after mastectomy, failure of patients receiving a
Publikováno v:
Cancer. 38(2)
Activities of glucosephosphate isomerase, lactate dehydrogenase, and NADP-isocitrate dehydrogenase were significantly elevated in breast cancer specimens from patients who responded favorably to combination cytotoxic chemotherapy regimens compared wi
Publikováno v:
Cancer chemotherapy reports. 58(6)
Autor:
W H, Schwesinger, H R, Bailey, P C, Canizaro, F L, Lanza, J D, McCracken, J P, O'Leary, E D, Savlov, N B, Searle, J R, Stroehlein, R F, Wells
Publikováno v:
Texas medicine. 83(9 Pt 2)
Publikováno v:
Cancer. 47(9)
Primary breast cancers from 54 patients undergoing postsurgical adjuvant chemotherapy were analyzed for several enzymes and estrogen receptors to determine if biochemical parameters might offer a prognostic index for determining outcome of therapy. R
Publikováno v:
Cancer treatment reports. 65(1-2)
In this patient series, doxorubicin and cycloleucine at a dose of 300 mg/kg both show response rates in the treatment of advanced soft tissue sarcomas of about 15%. Lower doses of cycloleucine (200 mg/kg) yielded less toxicity but were less effective
Publikováno v:
Cancer. 46
The possible relationship between estrogen receptors and response of breast cancer patients to chemotherapy was examined in two situations: patients with advanced disease and patients receiving post-surgical adjuvant treatment. In 73 patients with di
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. (57)